IAF, LLC 4
4 · Comera Life Sciences Holdings, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
IAF, LLC
Other
Transactions
- Purchase
Warrants to Purchase Common Stock
2023-12-29+7,636,362→ 7,636,362 totalExercise: $0.06From: 2023-12-29Exp: 2028-12-29→ Common Stock (7,636,362 underlying) - Purchase
12.0% Senior Secured Convertible Notes
2023-12-29$210000.00/shExercise: $0.06From: 2023-12-29Exp: 2024-12-29→ Common Stock (3,818,181 underlying)
Footnotes (1)
- [F1]The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.